Ticker
MXCTCompany Name
MAXCYTE INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 217.48M | $ 1.18M | $ 0 | $ 0 | -0.54% |
3/31/2025 | $ 258.35M | $ 1.74M | $ 0 | $ 0 | -0.67% |
12/31/2024 | $ 367.92M | $ 2.06M | $ 0 | $ 0 | -0.56% |
9/30/2024 | $ 409.27M | $ 2.14M | $ 0 | $ 0 | -0.52% |
6/30/2024 | $ 467.65M | $ 1.95M | $ 0 | $ 0 | -0.42% |
3/31/2024 | $ 410.86M | $ 1.39M | $ 0 | $ 0 | -0.34% |
12/31/2023 | $ 414.43M | $ 2.14M | $ 0 | $ 0 | -0.52% |
9/30/2023 | $ 346.98M | $ 2.88M | $ 0 | $ 0 | -0.83% |
6/30/2023 | $ 451.28M | $ 3.28M | $ 0 | $ 0 | -0.73% |
3/31/2023 | $ 479.19M | $ 3.45M | $ 0 | $ 0 | -0.72% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for MAXCYTE INC is calculated as follows: (-1 * CF - Equity [ $ 28.97M ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ -63.7K ]) / Market Cap [ $ 0 ]
(=) Shareholder Yield [ 0% ]
Minimum
Mar 31, 2022
Maximum
Mar 31, 2024
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.57% |
median | 1.07% |
std | 11.13% |